Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now

Shares of Monopar Therapeutics Inc. (MNPR) have been struggling lately and have lost 13.2% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road. While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about t ...